Previous studies have demonstrated the importance of antibodies in mediating immunity to malaria, but the relative contribution of the different immunoglobulin isotypes has not been assessed. In this study, hyperimmune plasma was generated against Plasmodium yoelii and separated by protein A-Sepharose chromatography into fractions containing immunoglobulin Gl (IgGl), IgG2a, IgG2b, or IgG3 antibodies and the remaining nonbinding plasma proteins, including IgM. Following concentration, the antimalarial titer of each isotypic fraction was approximately equivalent to the corresponding isotype in hyperimmune plasma. The isotypic fractions were passively transferred to BALB/c and outbred ICR mice prior to challenge with virulent P. yoelii 17XL and to CBA/CaJ mice challenged with avirulent P. yoelii 17XNL. Only mice receiving IgG2a antibodies experienced an altered course of infection. Immunoprecipitation studies showed that all four IgG isotypes appear to recognize a similar set of antigens. These results suggest that antimalarial antibodies of the IgG2a isotype play a dominant role in modulating P. yoelii parasitemias.
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Nonlethal Plasmodium yoelii 17X (17XNL) produces a self-resolving infection in mice, with parasitemias becoming subpatent in approximately 3 weeks (22) . Immunity to this parasite is largely humoral in nature. Jayawardena et al. (9) demonstrated that the passive transfer of hyperimmune serum to CBA mice completely protected them against challenge with 104 P. yoelii 17XNL-parasitized erythrocytes (PRBC). In addition, passively transferred antibodies (Ab) delayed the onset of infection when larger inocula (5 x 104 or 1 x 105 PRBC) were used (9) . Similar results have been reported for BALB/c mice (5) .
A heterogenous Ab response is induced by P. yoelii. Langhorne et al. investigated the antimalarial Ab response to P. yoelii 17XNL in C3H mice and found that immunoglobulin M (IgM), IgGl, IgG2, and IgG3 Ab were produced, with the highest titers being of the IgG2 isotype (13) . Recently, Taylor et al. investigated the anti-P. yoelii 17XNL response in 11 inbred strains of mice and determined that the strains varied in their isotypic response to the parasite (21) . The largest difference was seen with Ab of the IgGl isotype, in that only 3 of 11 strains produced detectable antimalarial Ab of this isotype during primary infection. All strains produced IgM, IgG2, and IgG3 Ab, although the kinetics of these responses varied among the strains.
Different strains of inbred mice also produce antimalarial Ab of various antigenic specificities (19) . When sera collected on days 11 and 21 of primary infection were used to immunoprecipitate metabolically labeled P. yoelii proteins, different patterns of reactivity were observed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and autoradiography.
The ability of mice to produce anti-P. yoelii 17XNL Ab of different isotypes and specificities raises two key questions: (i) is the protective capacity of hyperimmune plasma (HIP) found predominantly in a particular isotype, and (ii) do Ab of * Corresponding author. boosted up to four additional times with P. yoelii 17XL. Plasma was collected and pooled for each group of mice 7 to 10 days after the final injection and stored at -20°C.
Protein A chromatography. The protocols for protein A chromatography described by Ey et al. (2) and Seppala et al. (15) were essentially followed. Aliquots of 1 to 3 ml of HIP were adjusted to pH 8.0 with an equal volume of Tris-HCl buffer, pH 8.0 (56 mM Tris-HCl, 0.15 M NaCl), and applied to a column containing protein A-Sepharose (CL-4B; Pharmacia LKB Biotechnology Inc., Piscataway, N.J.) with a bed volume of 13 ml. Protein A-agarose (Life Technologies, Inc., Gaithersburg, Md.) was found to work equally well. Nonbinding material including IgM was washed through the column and is referred to as the nonbinding-IgM fraction. Bound IgG Ab were eluted from the column by using a linear pH gradient from pH 7.0 to 3.0 formed by mixing equal volumes (50 ml) of Tris-HCl buffer, pH 7 (0.1 M Tris-HCl, 0.15 M NaCl), and acetate buffer, pH 3 (3 mM sodium acetate, 0.15 M NaCI). Fractions (2 ml) were collected, appropriately pooled, and dialyzed against 0.1 M phosphatebuffered saline, pH 7.4 (PBS). Pooled isotypic fractions were concentrated by using an Amicon Minicell-Ultrafiltration system equipped with a YM-10 filter, such that fractions contained an antimalarial Ab titer approximately equivalent to that of the corresponding isotype in unseparated HIP (see below). The isotypic fractions were stored with 0.01% sodium azide at 4°C until used.
Heavy chain isotype-specific assays. In initial studies, HIP and the concentrated isotypic fractions were assayed for the presence of antimalarial Ab by the direct isotype-specific, solid-phase radioimmunoassay previously described by Kim et al. (11) . In this assay, antisera specific for heavy chain IgM, IgGl, IgG2 (both IgG2a and IgG2b), and IgG3 were employed. The specificities and specific activities of these reagents have been described previously (20) . Ab titers were determined by using an endpoint of 25% maximum specific binding.
In subsequent studies, a "triple-sandwich" isotype-specific enzyme immunoassay (EIA) was used. Ag for the EIA was prepared by collecting blood from ICR mice infected with P. yoelii 17XL. The blood cells were suspended in PBS and passed over a CF-li cellulose column to remove the leukocytes (8) . Then the RBC were layered on a one-step 55% Percoll For the isotype-specific EIA, an aliquot of PRBC was freeze-thawed three times and the protein concentration was determined spectrophotometrically (11) . Then, 100 ,I of the Ag solution containing 30 ,ug of parasite protein was added to polystyrene microtiter wells (Nunc-Immuno II; Nunc, Kamstrup, Denmark) and incubated overnight at 4°C. Plates were washed three times with PBS-0.1% Tween 20 and blocked with 10% milk in PBS for 2 h at room temperature. Serial 10-fold dilutions (100 ,ul) of mouse plasma in 1% milk-PBS were added in duplicate, and the plates were incubated overnight (4°C). Plates were washed as before, and 100 ,ul of a 1:1,000 dilution of goat anti-mouse IgM (kindly provided by R. Asofsky, National Institutes of Health); IgGl, IgG2a, or IgG3 (Southern Biotechnology Associates, Inc., Birmingham, Ala.); or IgG2b (Sigma) per well was added. The specificity of each of these reagents was confirmed prior to use. After an overnight incubation (4°C), the plates were washed and horseradish peroxidase-conjugated rabbit antigoat immunoglobulin (Southern Biotechnology) diluted 1:8,000 in 1% milk in PBS was added (100 ILI per well). The plates were incubated (3 h at room temperature) and washed, and the color was developed by adding 100 pI of azino-di [3- ethyl-benzthiazoline sulfonate] (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, Md.) per well. Ab titers were determined by using an endpoint of 25% maximum specific binding.
Passive transfer studies. Details for individual passive transfer experiments are provided below or in figure legends. In general, groups of three to five mice were injected intraperitoneally with 0.45 to 0.75 ml of one of the isotypic fractions, saline, normal mouse plasma (NMP), or HIP and challenged 2 to 5 h later with 10" to 106 PRBC. In some experiments, the mice received a second injection of Ab.
Metabolic labeling of P. yoelii 17XL parasites. The method for metabolic labeling of P. yoelii parasites has been described previously (13) . The culture medium consisted of 90% SELECTAMINE (GIBCO) and 10% complete medium. The directions for preparing SELECTAMINE were followed when labeling with [3H]Leu was performed. When labeling with a 14C-amino acid mixture, 10% of the recommended concentration of the contained amino acids was used. Complete medium (100 ml) consisted of 0.34 ml of L-glutamine (29 mglml of stock), 0.2 g of glucose, 0.6 g of N-2-hydroxyethylpiperazinc-N'-2-ethanesulfonic acid (HEPES), 3 ml of 7.5% sodium bicarbonate, 1 ml of hypoxanthine (0.5 mglml), 1.5% fetal bovine serum, and 94. a HIP used in this study was from BALB/c mice that had been injected with 17XNL once and 17XL five times. The fractions were transferred to mice as indicated in the legend to Fig. 1A .
b Boldface type indicates the Ab titer in HIP and the corresponding isotypic fractions. The lowest dilution tested was 1:10.
c On the basis of elution profiles, the majority of the contaminating IgG2 in the IgG3 fraction appears to be of the IgG2a isotype.
an unpaired, one-sided Student's t test. Data for survival times are expressed as mean ± standard deviation.
RESULTS
Initial studies using HIP from BALB/c mice. BALB/c HIP with a titer of >1:10,000,000 by radioimmunoassay was separated by protein A chromatography and used in passive transfer studies (Table 1 and Fig. 1 ). Radioimmunoassay analysis of the isotypic fractions showed that only antimalarial IgM was detected in the nonbinding-IgM fraction and that the IgGl, IgG2a, and IgG2b fractions were essentially pure, i.e., free of other IgG isotypes. However, there was a significant amount of contaminating IgG2a in the IgG3 fraction. An attempt was made to concentrate each IgG isotypic fraction such that it had a titer equivalent to that of its corresponding isotype in HIP. Results showed that desired titers were obtained for the IgM and IgG2 fractions, the IgGl fraction titer was slightly low, and the IgG3 fraction titer was slightly high (Table 1) .
To test the protective potential of the fractions, mice received 0.75 ml of either one of the above isotypic fractions or HIP intraperitoneally 2 h prior to challenge with 106 P. yoelii 17XL PRBC (Fig. 1A) . Results show that all mice receiving the IgGl, IgG2b, or IgG3 fraction developed courses of infection similar to those of saline controls and had a similar mean day of death (8.1 + 2.1 days, n = 5, versus saline control, 6.4 ± 0.5 days, n = 16). Mice receiving the nonbinding-IgM fraction had an altered course of infection with parasitemia and survival time of 12.2 ± 3.0 days. The mice receiving the IgG2a fraction survived still longer (17.4 ± 3.3 days, n = 5, P < 0.005) than the saline controls, and their mean survival time was comparable to that of the HIP controls (mean survival time, 20.8 ± 2.0 days). Thus, the IgG2a fraction was the most effective serum component in modulating parasitemia.
In the experiment described above, mice received a single injection of Ab. To determine whether the additional transfer of IgG2a Ab would more closely mimic HIP, mice received 0.5 ml of purified IgG2a or HIP at the time of infection and on day 2. Mice were challenged with 106 P. yoelii 17XL PRBC. Results showed that two injections of IgG2a resulted in protection equivalent to that produced by HIP (Fig. 1B) .
HIIP from additional sources. HIP was produced in ICR and CBA/CaJ mice as described in Materials and Methods and then fractionated, concentrated, and analyzed by the a- isotype-specific EIA. Reagents specific for IgG2a and IgG2b were included to more accurately evaluate Ab titers and purity. In the four separate fractionation experiments (two ICR and two CBA) no obvious differences in either purity or titer of ICR and CBA HIP were observed, so the data have been averaged (Table 2 ). In Table 2 , the isotypic fractions have been arranged in the sequence they elute from the protein A column. As can be seen, the mean Ab titer of each IgG isotypic fraction was essentially identical to that of the corresponding isotype present in HIP. The nonbinding-IgM fraction and IgGl and IgG2b fractions contained only minimal contamination from adjacent peaks. However, there was considerable cross contamination between the IgG2a and IgG3 fractions. The isotypic fractions were used in the studies discussed below (see Fig. 2 to 4 ). had antimalarial Ab titers approximately equivalent to those present in ICR HIP (Table 3) . In this experiment, titers in the IgGl and IgG2b fractions were higher than in HIP, the IgG3 titers were equivalent, but the titer of the IgG2a fraction was low (Table 3 ). For comparison, BALB/c HIP and the IgG2a fraction from BALB/c HIP were also used. The titer of the BALB/c IgG2a fraction was adjusted to that of the IgG2a level in ICR HIP (i.e., titer of 1:500,000 [log1o 5.7] ; Table 3 ).
BALB/c mice were injected with 0.45 ml of one of the isotypic fractions, NMP, ICR HIP, or BALB/c HIP and challenged S h later with 104 P. yoelii 17XL PRBC. Each mouse received a second injection of either plasma or the isotypic fraction 2 days later. The results, summarized in Fig. 2 , show that mice receiving NMP, IgGl, IgG2b, IgG3, and the nonbinding-IgM fraction experienced a course of infection similar to that of untreated control mice. The mean survival time of the mice in these groups was 10.2 ± 1.5 days. Mice which received IgG2a Ab from either the ICR or BALB/c HIP had a delay in the onset of the infection and lived significantly longer (18.7 ± 3.6 days, P < 0.005) than mice in the above groups. The mice which received the ICR HIP had a mean survival time of 19 ± 5.0 days. In contrast, mice which received BALB/c HIP had a mean survival time of 28 ± 4.4 days. It should be noted that the IgG2a titer in BALB/c HIP was 1:2,500,000, compared with 1:500,000 in Effect of isotype on nonlethal (17XNL) P. yoelii infection. To determine whether IgG2a Ab were also effective in controlling nonlethal malaria, the P. yoelii 17XNL-CBA/CaJ model was used, as a uniformly nonlethal infection is produced in this mouse strain. CBA HIP was fractionated, the purity of the fractions was assessed (Table 2) , and specific Ab titers were determined (Table 3) . As can be seen in Table 3 , the Ab titers in each fraction closely approximated those found in the CBA HIP from which they were obtained. CBA mice were injected with either one of the isotypic fractions or CBA HIP and then challenged 5 h later with P. yoelii 17XNL PRBC. The mice received a second injection of the same fraction or HIP 2 days later. Results are shown in Fig. 3 . Mice receiving IgGl, IgG2b, IgG3, or the nonbinding-IgM fraction experienced a course of infection very similar to that of the untreated control mice. All mice in these groups developed patent infections by day 4 (parasitemias ranging from 0.2 to 4.4%). They developed mean peak parasitemias of 10 to 12% and cleared the infection by day 16 to 17. In contrast, all three mice receiving the IgG2a fraction did not develop patent infections until day 10 to 12, suggesting control of the infection by the passively transferred IgG2a Ab. Thereafter, parasitemias continued to climb and the mice developed a mean peak parasitemia that was significantly higher than that of mice receiving the other isotypic fractions (P s 0.005). Mice receiving IgG2a cleared the infection by day 27. Thus, the length of patent parasitemia was similar in all mice (range, 11 to 14 days). CBA mice receiving CBA HIP were completely protected; i.e., they did not develop patent infections. Thus, again, the only purified isotypic fraction that modulated parasitemia was the IgG2a fraction.
Immunoprecipitation studies. To determine whether Ab of the IgG2a isotype recognized unique P. yoelii antigens, aliquots of isotypic fractions from BALB/c and ICR HIP were incubated with extracts of P. yoelii 17XL parasites metabolically labeled in vitro with [3H]Leu or a mixture of 14C-amino acids. The isotypic fractions used are listed in Tables 1 and 2 . Results show that Ab of each of the different IgG subclasses precipitated a similar series of bands (Fig. 4 ). There were no unique bands present in the IgG2a fractions obtained from BALB/c or ICR mice. In additional experiments, several different concentrations of ICR IgG2a Ab were used (including twice the concentration shown here), but unique reactivities were never observed (data not shown). This suggests that the partially protective effect of IgG2a Ab observed in passive transfer studies was not due to the recognition of one or more isotype-restricted P. yoelii antigens. When the IgGl fraction of BALB/c HIP was used, an apparent unique band with an Mr of approximately 45,000 was seen. This suggests that the isotypic fractions were probably pure enough to detect unique reactivities had they been present.
DISCUSSION
Previous studies have shown that the passive transfer of hyperimmune serum to mice significantly modulates the course of P. yoelii infections (5, 9), but little is known about the nature of the protective component within immune sera. Results of the current study show that HIP contains anti-P. yoelii Ab of all the isotypes examined. This finding confirms earlier reports (13, 21) and extends them by demonstrating that both IgG2a and IgG2b are present.
The HIP used in these studies was from mice that had been injected with viable P. yoelii PRBC two to six times. Previous studies have shown that anti-P. yoelii Ab titers do not increase beyond the second or third exposure (18) . Thus, maximal amounts of each of the isotypes were present in the HIP used. On the basis of the data from Table 2 , the highest titer of antimalarial Ab was found in the IgG2a subclass (log1o 5.6), with slightly lower titers in IgGl (log1o 5.2), IgG2b (log1o 4.8) , and IgG3 (log1o 4.6), respectively. Thus, the titers of the four IgG isotypes differed by only a mean of 1 log1o. This is interesting on the basis of the observations that lymphokines released by TH1 and TH2 cells regulate IgG isotype expression. Gamma interferon produced by TH1 cells enhances IgG2a production and suppresses IgGl, whereas interleukin-4 produced by TH2 cells enhances IgGl synthesis and suppresses other IgG isotypes (17) . Thus, there is no direct evidence that one of the T helper subsets predominates over the other in mice that have been infected several times.
Since HIP modulates parasitemias, two questions arose: (i) are protective Ab equally distributed atnong all the isotypes studied, and (ii) would a single isotype be capable of modulating infection, or would several isotypes or classes be required? Results of this study demonstrate that at physiological levels, Ab of the IgG2a isotype are predominantly responsible for modulating parasitemias in passive transfer studies. The nonbinding-IgM fraction had a minor effect in some but not all experiments. This fraction should contain IgM antimalarial Ab and possibly cytokines. Although IgGl titers are high in HIP, it is uncertain whether IgGl Ab play a key role in protection. For example, when isotypic fractions of ICR HIP were transferred to BALB/c mice (Table 3 and Fig. 2) , the antimalarial titer in the IgGl fraction was greater than in the IgG2a fraction (IgGl fraction, log1o 6.2; IgG2a fraction, log1o 5.3 ), yet IgGl Ab did not alter the course of infection (Fig. 2) . The titer in the IgGl fraction in this particular experiment was greater than that normally found in HIP (IgGl fraction, log1o 6.2; HIP, log1o 5.2); thus, even artificially elevated levels of IgGl were not effective. IgG2b and IgG3 Ab, which are not effective when used at physiological levels, might alter parasitemias if they were present in higher concentrations; however, they do not reach levels beyond those present in the HIP used in this study. The combined data highly suggest that antimalarial Ab of the IgG2a isotype are predominantly responsible for the protection observed in passive Ab transfer studies. (25, 26, 27) . In addition, these authors found a positive correlation between the ability of sera from different strains of mice to kill T. musculi in vitro (27) and IgG2a trypanosome-specific Ab titers. They suggest that IgG2a Ab mediates its effect against this parasite by complementmediated lysis (25, 27) .
It is not clear why Ab of the IgG2a isotype are best at conferring passive protection to P. yoelii-infected mice. Immunoprecipitation studies suggest that they do not react with unique P. yoelii Ag (Fig. 4) ; however, additional biochemical studies are needed before this possibility can be ruled out. In the passive transfer studies, there was a long lag phase in detection of patent parasitemias with both the 17XL and 17XNL infections (Fig. 1 to 3) . These results suggest that passively transferred Ab helped to eliminate parasites within the initial inoculum. There are two known mechanisms by which antimalarial Ab mediate their effects, namely, by blocking an important receptor-ligand interaction (e.g., blocking freed merozoites from entering RBC) and enhancing Fc-mediated phagocytosis (1) . Passive protection against P. yoelii has been achieved with monoclonal Ab of the IgGl, IgG2a, and IgG3 isotypes (6, 14) . These monoclonal Ab are directed against merozoites and may prevent merozoite interaction with the RBC. Such an action would not require the effector functions of a particular isotype but would require appropriate idiotypic specificity. Several investigators have shown that during the early stages of rodent malaria, Ig-coated RBC are ingested by activated macrophages (16, 23) . Since activated macrophages have enhanced expression of Fc receptors for IgG2a Ab (3), it is possible that macrophages preferentially phagocytize PRBC or merozoites that have been opsonized by Ab of the IgG2a isotype.
Studies of human malaria demonstrate a correlation between protective immunity and the presence of opsonic Ab (7). Although both mechanisms could be operative in the current study, it is likely that IgG2a Ab are mediating their effects primarily by Fc-mediated phagocytosis, since there is no evidence that IgG isotypes differ in antigenic specificity.
IgG isotypes are thought to be important in human immunity to malarial parasites. Wahlgren and colleagues found in indirect immunofluorescence Ab studies that Ab of all isotypes give strong parasite reactivity but IgG2 Ab were unique in giving staining restricted to the surface of schizonts (24) . Recent toanti-RBC Ab of these isotypes may also be involved in producing hemolytic anemia (4) . Thus, there is much to be learned about the role of Ab isotype in both protection from and the pathogenesis of malaria.
Results of this study suggest that Ab of the IgG2a isotype are important in immunity to P. yoelii in mice, and results with humans (4, 7, 24) suggest that Ig-isotype expression is likely to be important in immunity to P. falciparum. Today, there is interest in the production of a vaccine for malaria which will probably need to be administered with an adjuvant. If so, care should be taken in selection of the adjuvant, since different adjuvants stimulate the expression of different isotypes (10) . Thus, in developing a vaccine, investigators may need to consider both isotype expression and the induction of high titers of high-affinity Ab.
